JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Saved in:
Bibliographic Details
Title: JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Authors: Salas A; Department of Gastroenterology, IDIBAPS, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain., Hernandez-Rocha C; Zane Cohen Center for Digestive Diseases, Mount Sinai Hospital Inflammatory Bowel Disease Group, Toronto, Ontario, Canada., Duijvestein M; Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Faubion W; Gastroenterology and Hepatology, Mayo Clinic, Rochester, MI, USA., McGovern D; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Vermeire S; Department of Gastroenterology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Vetrano S; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IBD Center, Laboratory of Immunology in Gastroenterology, Humanitas Clinical and Research Center IRCCS, Milan, Italy., Vande Casteele N; Robarts Clinical Trials, London, ON, Canada. nvandecasteele@health.ucsd.edu.; Department of Medicine, University of California San Diego, La Jolla, CA, USA. nvandecasteele@health.ucsd.edu.
Source: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2020 Jun; Vol. 17 (6), pp. 323-337. Date of Electronic Publication: 2020 Mar 19.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500079 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-5053 (Electronic) Linking ISSN: 17595045 NLM ISO Abbreviation: Nat Rev Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-5053
DOI:10.1038/s41575-020-0273-0